Athens, Ga. -- U.S. scientists have created a vaccine that in an animal study successfully generated protection against cancer cells.
The researchers at the University of Georgia Cancer Center synthesized a carbohydrate-based vaccine that -- in mice -- successfully triggered a strong immune response to cancer cells.
"In mice we can illicit very strong antibody responses and we have shown that the antibody responses are functional -- that they can kill cancer cells," said Professor Geert-Jan Boons, lead author of the student.
Vaccines usually prevent diseases by priming the immune system to recognize and attack a virus or bacteria. But the vaccine Boons and colleagues developed is a therapeutic vaccine that trains the body's immune system to fight an existing disease.
"We needed to come up with a vaccine that does not give our immune system a chance to go after anything else but the tumor-associated carbohydrate," Boons said. "In other words, there should no junk that can induce an immune response to something other than the tumor-associated carbohydrate."
The research is reported in the journal Nature Chemical Biology.
Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision.
Recent comments
1 day 19 hours ago
1 day 20 hours ago
1 day 21 hours ago
1 day 23 hours ago
2 days 19 hours ago
3 days 2 hours ago
3 days 2 hours ago
3 days 5 hours ago
3 days 5 hours ago
3 days 23 hours ago